UniProt ID | TM87A_HUMAN | |
---|---|---|
UniProt AC | Q8NBN3 | |
Protein Name | Transmembrane protein 87A {ECO:0000305} | |
Gene Name | TMEM87A {ECO:0000312|HGNC:HGNC:24522} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 555 | |
Subcellular Localization |
Golgi apparatus membrane Multi-pass membrane protein . |
|
Protein Description | May be involved in retrograde transport from endosomes to the trans-Golgi network (TGN).. | |
Protein Sequence | MAAAAWLQVLPVILLLLGAHPSPLSFFSAGPATVAAADRSKWHIPIPSGKNYFSFGKILFRNTTIFLKFDGEPCDLSLNITWYLKSADCYNEIYNFKAEEVELYLEKLKEKRGLSGKYQTSSKLFQNCSELFKTQTFSGDFMHRLPLLGEKQEAKENGTNLTFIGDKTAMHEPLQTWQDAPYIFIVHIGISSSKESSKENSLSNLFTMTVEVKGPYEYLTLEDYPLMIFFMVMCIVYVLFGVLWLAWSACYWRDLLRIQFWIGAVIFLGMLEKAVFYAEFQNIRYKGESVQGALILAELLSAVKRSLARTLVIIVSLGYGIVKPRLGVTLHKVVVAGALYLLFSGMEGVLRVTGAQTDLASLAFIPLAFLDTALCWWIFISLTQTMKLLKLRRNIVKLSLYRHFTNTLILAVAASIVFIIWTTMKFRIVTCQSDWRELWVDDAIWRLLFSMILFVIMVLWRPSANNQRFAFSPLSEEEEEDEQKEPMLKESFEGMKMRSTKQEPNGNSKVNKAQEDDLKWVEENVPSSVTDVALPALLDSDEERMITHFERSKME | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
46 | Ubiquitination | RSKWHIPIPSGKNYF HHCCCCCCCCCCCCE | 4.13 | 29967540 | |
48 | Phosphorylation | KWHIPIPSGKNYFSF CCCCCCCCCCCCEEC | 64.22 | 24719451 | |
56 | Ubiquitination | GKNYFSFGKILFRNT CCCCEECCEEEEECC | 18.20 | 29967540 | |
79 | N-linked_Glycosylation | EPCDLSLNITWYLKS EECEEEEEEEEEECC | 26.69 | UniProtKB CARBOHYD | |
90 | Ubiquitination | YLKSADCYNEIYNFK EECCCCCCHHHHCCC | 19.17 | 29967540 | |
104 | Phosphorylation | KAEEVELYLEKLKEK CHHHHHHHHHHHHHH | 10.18 | - | |
107 | Ubiquitination | EVELYLEKLKEKRGL HHHHHHHHHHHHCCC | 63.36 | 29967540 | |
115 | Phosphorylation | LKEKRGLSGKYQTSS HHHHCCCCCCCCCHH | 35.74 | 29083192 | |
117 | Ubiquitination | EKRGLSGKYQTSSKL HHCCCCCCCCCHHHH | 30.70 | 29967540 | |
118 | Phosphorylation | KRGLSGKYQTSSKLF HCCCCCCCCCHHHHH | 22.13 | 29083192 | |
120 | Phosphorylation | GLSGKYQTSSKLFQN CCCCCCCCHHHHHHH | 31.70 | 29083192 | |
121 | Phosphorylation | LSGKYQTSSKLFQNC CCCCCCCHHHHHHHH | 15.22 | 29083192 | |
122 | Phosphorylation | SGKYQTSSKLFQNCS CCCCCCHHHHHHHHH | 36.44 | 29083192 | |
127 | N-linked_Glycosylation | TSSKLFQNCSELFKT CHHHHHHHHHHHHCC | 24.77 | UniProtKB CARBOHYD | |
151 | Ubiquitination | RLPLLGEKQEAKENG HCCCCCCCHHHHHHC | 52.20 | 29967540 | |
157 | N-linked_Glycosylation | EKQEAKENGTNLTFI CCHHHHHHCCCCEEE | 62.98 | 19349973 | |
160 | N-linked_Glycosylation | EAKENGTNLTFIGDK HHHHHCCCCEEECCC | 38.18 | 19349973 | |
168 (in isoform 2) | Phosphorylation | - | 33.67 | 22985185 | |
196 | Phosphorylation | GISSSKESSKENSLS ECCCCCCCCCCCCCC | 50.90 | - | |
197 | Phosphorylation | ISSSKESSKENSLSN CCCCCCCCCCCCCCC | 45.11 | - | |
201 | Phosphorylation | KESSKENSLSNLFTM CCCCCCCCCCCCEEE | 33.98 | 27732954 | |
203 | Phosphorylation | SSKENSLSNLFTMTV CCCCCCCCCCEEEEE | 31.16 | 27732954 | |
207 | Phosphorylation | NSLSNLFTMTVEVKG CCCCCCEEEEEEEEC | 18.33 | 27732954 | |
209 | Phosphorylation | LSNLFTMTVEVKGPY CCCCEEEEEEEECCC | 15.51 | 27732954 | |
256 | Ubiquitination | ACYWRDLLRIQFWIG HHHHHHHHHHHHHHH | 5.48 | 21890473 | |
257 | Ubiquitination | CYWRDLLRIQFWIGA HHHHHHHHHHHHHHH | 28.14 | 21890473 | |
310 | Phosphorylation | VKRSLARTLVIIVSL HHHHHHHHHHHHHHC | 21.55 | - | |
336 | Ubiquitination | TLHKVVVAGALYLLF CHHHHHHHHHHHHHH | 5.97 | 21890473 | |
336 (in isoform 3) | Ubiquitination | - | 5.97 | 21890473 | |
337 | Ubiquitination | LHKVVVAGALYLLFS HHHHHHHHHHHHHHC | 12.42 | 21890473 | |
343 | Ubiquitination | AGALYLLFSGMEGVL HHHHHHHHCCCCCHH | 5.68 | 22817900 | |
344 | Ubiquitination | GALYLLFSGMEGVLR HHHHHHHCCCCCHHH | 36.88 | 22817900 | |
348 | Ubiquitination | LLFSGMEGVLRVTGA HHHCCCCCHHHHCCC | 18.18 | 21963094 | |
349 | Ubiquitination | LFSGMEGVLRVTGAQ HHCCCCCHHHHCCCC | 1.64 | 21963094 | |
355 | Ubiquitination | GVLRVTGAQTDLASL CHHHHCCCCCHHHHH | 10.34 | 23503661 | |
356 | Ubiquitination | VLRVTGAQTDLASLA HHHHCCCCCHHHHHC | 36.57 | 23503661 | |
357 | Phosphorylation | LRVTGAQTDLASLAF HHHCCCCCHHHHHCH | 32.23 | - | |
360 | Ubiquitination | TGAQTDLASLAFIPL CCCCCHHHHHCHHHH | 12.81 | 23503661 | |
361 | Ubiquitination | GAQTDLASLAFIPLA CCCCHHHHHCHHHHH | 27.77 | 23503661 | |
361 | Phosphorylation | GAQTDLASLAFIPLA CCCCHHHHHCHHHHH | 27.77 | - | |
368 | Ubiquitination | SLAFIPLAFLDTALC HHCHHHHHHHHHHHH | 9.52 | 22817900 | |
369 | Ubiquitination | LAFIPLAFLDTALCW HCHHHHHHHHHHHHH | 9.27 | 22817900 | |
371 | Ubiquitination | FIPLAFLDTALCWWI HHHHHHHHHHHHHHH | 24.39 | 22817900 | |
372 | Ubiquitination | IPLAFLDTALCWWIF HHHHHHHHHHHHHHH | 24.55 | 22817900 | |
378 | Ubiquitination | DTALCWWIFISLTQT HHHHHHHHHHHHHHH | 0.67 | 22817900 | |
379 | Ubiquitination | TALCWWIFISLTQTM HHHHHHHHHHHHHHH | 1.63 | 22817900 | |
397 | Ubiquitination | KLRRNIVKLSLYRHF HHHHHHHHHHHHHHH | 28.67 | 22817900 | |
397 (in isoform 1) | Ubiquitination | - | 28.67 | 21890473 | |
398 | Ubiquitination | LRRNIVKLSLYRHFT HHHHHHHHHHHHHHH | 2.71 | 21890473 | |
415 | Phosphorylation | LILAVAASIVFIIWT HHHHHHHHHHHHHHH | 15.00 | 30576142 | |
423 | Ubiquitination | IVFIIWTTMKFRIVT HHHHHHHHCCEEEEE | 11.90 | 22817900 | |
423 (in isoform 3) | Ubiquitination | - | 11.90 | 21890473 | |
424 | Ubiquitination | VFIIWTTMKFRIVTC HHHHHHHCCEEEEEE | 2.78 | 22817900 | |
428 | Ubiquitination | WTTMKFRIVTCQSDW HHHCCEEEEEECCCH | 3.19 | 21963094 | |
428 (in isoform 3) | Ubiquitination | - | 3.19 | 21890473 | |
429 | Ubiquitination | TTMKFRIVTCQSDWR HHCCEEEEEECCCHH | 3.69 | 21963094 | |
435 | Ubiquitination | IVTCQSDWRELWVDD EEEECCCHHHHHHHH | 10.82 | 33845483 | |
435 (in isoform 3) | Ubiquitination | - | 10.82 | - | |
436 | Ubiquitination | VTCQSDWRELWVDDA EEECCCHHHHHHHHH | 33.83 | 23503661 | |
440 | Ubiquitination | SDWRELWVDDAIWRL CCHHHHHHHHHHHHH | 8.15 | 23503661 | |
441 | Ubiquitination | DWRELWVDDAIWRLL CHHHHHHHHHHHHHH | 28.21 | 23503661 | |
448 | Ubiquitination | DDAIWRLLFSMILFV HHHHHHHHHHHHHHH | 1.93 | 22817900 | |
449 | Ubiquitination | DAIWRLLFSMILFVI HHHHHHHHHHHHHHH | 5.73 | 22817900 | |
451 (in isoform 3) | Ubiquitination | - | 2.12 | 21890473 | |
451 | Ubiquitination | IWRLLFSMILFVIMV HHHHHHHHHHHHHHH | 2.12 | 27667366 | |
452 | Ubiquitination | WRLLFSMILFVIMVL HHHHHHHHHHHHHHH | 2.33 | 22817900 | |
458 (in isoform 3) | Ubiquitination | - | 2.97 | 21890473 | |
458 | Ubiquitination | MILFVIMVLWRPSAN HHHHHHHHHHCCCCC | 2.97 | 22817900 | |
459 | Ubiquitination | ILFVIMVLWRPSANN HHHHHHHHHCCCCCC | 1.45 | 22817900 | |
472 | Phosphorylation | NNQRFAFSPLSEEEE CCCCEEECCCCHHHH | 22.85 | 30266825 | |
475 | Phosphorylation | RFAFSPLSEEEEEDE CEEECCCCHHHHHHH | 46.47 | 23401153 | |
479 | Phosphorylation | SPLSEEEEEDEQKEP CCCCHHHHHHHHHCC | 74.22 | 32142685 | |
484 (in isoform 1) | Ubiquitination | - | 62.83 | 21890473 | |
484 | Ubiquitination | EEEEDEQKEPMLKES HHHHHHHHCCHHHHH | 62.83 | 22817900 | |
485 | Ubiquitination | EEEDEQKEPMLKESF HHHHHHHCCHHHHHH | 35.32 | 22817900 | |
487 | Sulfoxidation | EDEQKEPMLKESFEG HHHHHCCHHHHHHCC | 9.77 | 21406390 | |
489 (in isoform 1) | Ubiquitination | - | 45.09 | 21890473 | |
489 | Ubiquitination | EQKEPMLKESFEGMK HHHCCHHHHHHCCCC | 45.09 | 21906983 | |
490 | Ubiquitination | QKEPMLKESFEGMKM HHCCHHHHHHCCCCC | 57.61 | 21963094 | |
491 | Phosphorylation | KEPMLKESFEGMKMR HCCHHHHHHCCCCCC | 27.32 | 29214152 | |
496 | Ubiquitination | KESFEGMKMRSTKQE HHHHCCCCCCCCCCC | 41.86 | 33845483 | |
497 | Ubiquitination | ESFEGMKMRSTKQEP HHHCCCCCCCCCCCC | 2.80 | 23503661 | |
501 | Ubiquitination | GMKMRSTKQEPNGNS CCCCCCCCCCCCCCC | 54.64 | 23503661 | |
502 | Ubiquitination | MKMRSTKQEPNGNSK CCCCCCCCCCCCCCC | 72.04 | 23503661 | |
509 | Ubiquitination | QEPNGNSKVNKAQED CCCCCCCCCCHHHHH | 54.55 | 22817900 | |
510 | Ubiquitination | EPNGNSKVNKAQEDD CCCCCCCCCHHHHHH | 9.98 | 22817900 | |
512 | Ubiquitination | NGNSKVNKAQEDDLK CCCCCCCHHHHHHHH | 55.20 | 21906983 | |
512 (in isoform 1) | Ubiquitination | - | 55.20 | 21890473 | |
513 | Ubiquitination | GNSKVNKAQEDDLKW CCCCCCHHHHHHHHH | 16.88 | 22817900 | |
519 (in isoform 1) | Ubiquitination | - | 57.07 | 21890473 | |
519 | Ubiquitination | KAQEDDLKWVEENVP HHHHHHHHHHHHHCC | 57.07 | 22817900 | |
520 | Ubiquitination | AQEDDLKWVEENVPS HHHHHHHHHHHHCCC | 15.28 | 22817900 | |
527 | Phosphorylation | WVEENVPSSVTDVAL HHHHHCCCCHHHCHH | 32.91 | 30266825 | |
528 | Phosphorylation | VEENVPSSVTDVALP HHHHCCCCHHHCHHH | 23.98 | 30266825 | |
530 | Phosphorylation | ENVPSSVTDVALPAL HHCCCCHHHCHHHHH | 27.06 | 30266825 | |
540 | Phosphorylation | ALPALLDSDEERMIT HHHHHCCCCHHHHHH | 47.06 | 22167270 | |
547 | Phosphorylation | SDEERMITHFERSKM CCHHHHHHHHHHHHC | 15.92 | 28450419 | |
552 | Phosphorylation | MITHFERSKME---- HHHHHHHHHCC---- | 29.20 | 28555341 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TM87A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TM87A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TM87A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ADAS_HUMAN | AGPS | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-157 AND ASN-160, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-540, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-540, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-540, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-540, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-540, AND MASSSPECTROMETRY. |